Home

Jose Carmona

CIK 1693612 · Chief Financial Officer · last filed 2026-07-02

Jose Carmona is a Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for ADCT, was dated Jul 2, 2026. Across all open-market trades the lifetime net is +$75.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.03M

Companies

3

Total Filings

13

Lifetime Open-Market Net

$75.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADCT Chief Financial Officer 938,076 $1.10 $1.03M $0 5 2026-07-02
Rubius Therapeutics, Inc. (RUBY) Delisted Chief Financial Officer — $0.08 — $0 2 2022-02-01
Radius Health, Inc. (RDUS) Delisted Chief Financial Officer 46,708 $30.00 $1.40M $75.3K 6 2020-02-28

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 ADCT Grant (A) +203,700 $0 EDGAR
2026-02-18 ADCT Mixed +245,720 $980.4K EDGAR
2025-12-09 ADCT Tax (F) −53,236 -$175.1K EDGAR
2025-02-14 ADCT Grant (A) +240,000 $386.4K EDGAR
2024-12-09 ADCT Tax (F) −48,108 -$150.6K EDGAR
2022-02-01 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2020-12-02 Rubius Therapeutics, Inc. (RUBY) Delisted Grant (A) — $0 EDGAR
2020-02-28 Radius Health, Inc. (RDUS) Delisted Sell (S) −1,292 -$23.2K EDGAR
2020-02-24 Radius Health, Inc. (RDUS) Delisted Grant (A) +30,000 $0 EDGAR
2019-02-26 Radius Health, Inc. (RDUS) Delisted Grant (A) +15,000 $0 EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.